✦ LIBER ✦

Cost-effectiveness of enzyme replacement therapy with alglucosidase alfa in classic-infantile patients with Pompe disease

✍ Scribed by Kanters, Tim A; Hoogenboom-Plug, Iris; Rutten-Van Mölken, Maureen PMH; Redekop, W; van der Ploeg, Ans T; Hakkaart, Leona

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Enzyme Replacement

✍ Kanters, T.A.; Plug, I.; Rutten-van Mölken, M.P.M.H.; Redekop, W.; Van der Ploeg 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

36 months observational clinical study o

✍ Regnery, Caroline; Kornblum, Cornelia; Hanisch, Frank; Vielhaber, Stefan; Strigl 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 273 KB

P3.55 CRIM status and antibody formation

✍ C.M. van Gelder; M.A. Kroos; L. Ozkan; A.T. van der Ploeg; A.J. Reuser 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

69 Case report of patient with infantile

✍ Judith Phalin; Berkley R. Powell; Susan C. Winter 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

13. Enzyme replacement therapy with Algl

✍ Bruno Bembi; Sabrina Ravaglia; Federica Edith Pisa; Giovanni Ciana; Agata Fiumar 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Desensitisation of the youngest patient

✍ Karagol, I.H.E.; Bakirtas, A.; Yilmaz, O.; Topal, E.; Kucukcongar, A.; Ezgu, F.S 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 348 KB